WEBVTT
Kind: captions
Language: en

00:00:00.000 --> 00:00:02.540 

hello<00:00:00.810> my<00:00:01.110> name<00:00:01.260> is<00:00:01.290> Ken<00:00:01.709> I<00:00:02.010> was<00:00:02.310> diagnosed

00:00:02.540 --> 00:00:02.550 
hello my name is Ken I was diagnosed

00:00:02.550 --> 00:00:04.490 
hello my name is Ken I was diagnosed
with<00:00:03.000> central<00:00:03.389> retinal<00:00:03.689> vein<00:00:03.720> occlusion<00:00:03.870> in

00:00:04.490 --> 00:00:04.500 
with central retinal vein occlusion in

00:00:04.500 --> 00:00:07.430 
with central retinal vein occlusion in
2002<00:00:05.339> I'm<00:00:06.000> not<00:00:06.180> a<00:00:06.240> doctor<00:00:06.509> and<00:00:06.990> I<00:00:07.080> have<00:00:07.259> no

00:00:07.430 --> 00:00:07.440 
2002 I'm not a doctor and I have no

00:00:07.440 --> 00:00:09.500 
2002 I'm not a doctor and I have no
medical<00:00:07.770> training<00:00:07.950> so<00:00:08.639> remember<00:00:08.880> to<00:00:09.030> consult

00:00:09.500 --> 00:00:09.510 
medical training so remember to consult

00:00:09.510 --> 00:00:11.570 
medical training so remember to consult
your<00:00:09.719> physician<00:00:09.960> without<00:00:10.650> delay<00:00:11.010> when<00:00:11.340> making

00:00:11.570 --> 00:00:11.580 
your physician without delay when making

00:00:11.580 --> 00:00:14.600 
your physician without delay when making
medical<00:00:12.000> decisions<00:00:13.190> after<00:00:14.190> being<00:00:14.370> diagnosed

00:00:14.600 --> 00:00:14.610 
medical decisions after being diagnosed

00:00:14.610 --> 00:00:16.910 
medical decisions after being diagnosed
with<00:00:15.299> central<00:00:15.690> retinal<00:00:16.080> vein<00:00:16.109> occlusion<00:00:16.260> in

00:00:16.910 --> 00:00:16.920 
with central retinal vein occlusion in

00:00:16.920 --> 00:00:20.000 
with central retinal vein occlusion in
one<00:00:17.160> eye<00:00:17.190> my<00:00:18.090> immediate<00:00:18.390> concern<00:00:18.630> was<00:00:19.380> what's

00:00:20.000 --> 00:00:20.010 
one eye my immediate concern was what's

00:00:20.010 --> 00:00:21.830 
one eye my immediate concern was what's
the<00:00:20.250> chance<00:00:20.550> that<00:00:20.699> something<00:00:21.119> like<00:00:21.480> this<00:00:21.779> is

00:00:21.830 --> 00:00:21.840 
the chance that something like this is

00:00:21.840 --> 00:00:24.490 
the chance that something like this is
going<00:00:22.410> to<00:00:22.500> happen<00:00:22.619> in<00:00:23.010> my<00:00:23.250> other<00:00:23.519> eye<00:00:23.670> in

00:00:24.490 --> 00:00:24.500 
going to happen in my other eye in

00:00:24.500 --> 00:00:27.109 
going to happen in my other eye in
medical<00:00:25.500> writings<00:00:25.920> this<00:00:26.279> other<00:00:26.550> eye<00:00:26.670> is

00:00:27.109 --> 00:00:27.119 
medical writings this other eye is

00:00:27.119 --> 00:00:29.980 
medical writings this other eye is
usually<00:00:27.660> referred<00:00:27.840> to<00:00:28.080> as<00:00:28.289> the<00:00:28.830> fellow<00:00:29.099> I<00:00:29.519> a

00:00:29.980 --> 00:00:29.990 
usually referred to as the fellow I a

00:00:29.990 --> 00:00:32.450 
usually referred to as the fellow I a
number<00:00:30.990> of<00:00:31.080> medical<00:00:31.470> studies<00:00:31.890> involving

00:00:32.450 --> 00:00:32.460 
number of medical studies involving

00:00:32.460 --> 00:00:34.880 
number of medical studies involving
retinal<00:00:32.880> vein<00:00:33.030> occlusion<00:00:33.200> patients<00:00:34.200> discuss

00:00:34.880 --> 00:00:34.890 
retinal vein occlusion patients discuss

00:00:34.890 --> 00:00:37.430 
retinal vein occlusion patients discuss
the<00:00:35.190> fellow<00:00:35.430> eye<00:00:35.579> you're<00:00:36.570> just<00:00:36.899> a<00:00:37.020> couple<00:00:37.260> of

00:00:37.430 --> 00:00:37.440 
the fellow eye you're just a couple of

00:00:37.440 --> 00:00:40.910 
the fellow eye you're just a couple of
examples<00:00:37.980> in<00:00:38.840> addition<00:00:39.840> to<00:00:40.200> specifying<00:00:40.469> how

00:00:40.910 --> 00:00:40.920 
examples in addition to specifying how

00:00:40.920 --> 00:00:43.910 
examples in addition to specifying how
many<00:00:41.280> patients<00:00:41.750> participated<00:00:42.750> reports<00:00:43.739> on

00:00:43.910 --> 00:00:43.920 
many patients participated reports on

00:00:43.920 --> 00:00:45.920 
many patients participated reports on
these<00:00:44.100> studies<00:00:44.520> will<00:00:44.760> often<00:00:45.180> disclose<00:00:45.690> the

00:00:45.920 --> 00:00:45.930 
these studies will often disclose the

00:00:45.930 --> 00:00:48.319 
these studies will often disclose the
number<00:00:46.200> of<00:00:46.320> patients<00:00:46.920> who<00:00:47.039> at<00:00:47.700> the<00:00:47.910> beginning

00:00:48.319 --> 00:00:48.329 
number of patients who at the beginning

00:00:48.329 --> 00:00:50.450 
number of patients who at the beginning
of<00:00:48.480> the<00:00:48.600> study<00:00:48.870> have<00:00:49.559> had<00:00:49.800> a<00:00:49.829> history<00:00:50.430> of

00:00:50.450 --> 00:00:50.460 
of the study have had a history of

00:00:50.460 --> 00:00:52.910 
of the study have had a history of
retinal<00:00:51.059> vein<00:00:51.210> occlusion<00:00:51.270> in<00:00:52.050> the<00:00:52.320> fellow<00:00:52.559> eye

00:00:52.910 --> 00:00:52.920 
retinal vein occlusion in the fellow eye

00:00:52.920 --> 00:00:55.130 
retinal vein occlusion in the fellow eye
or<00:00:53.280> have<00:00:53.969> retinal<00:00:54.390> vein<00:00:54.510> occlusions

00:00:55.130 --> 00:00:55.140 
or have retinal vein occlusions

00:00:55.140 --> 00:00:58.819 
or have retinal vein occlusions
currently<00:00:55.710> going<00:00:55.890> on<00:00:56.129> in<00:00:56.190> both<00:00:56.579> eyes<00:00:57.710> when<00:00:58.710> you

00:00:58.819 --> 00:00:58.829 
currently going on in both eyes when you

00:00:58.829 --> 00:01:00.500 
currently going on in both eyes when you
look<00:00:59.010> at<00:00:59.129> this<00:00:59.250> column<00:00:59.640> remember<00:01:00.120> that<00:01:00.329> the

00:01:00.500 --> 00:01:00.510 
look at this column remember that the

00:01:00.510 --> 00:01:02.630 
look at this column remember that the
large<00:01:00.780> medical<00:01:01.140> centers<00:01:01.770> involved<00:01:02.370> in<00:01:02.489> these

00:01:02.630 --> 00:01:02.640 
large medical centers involved in these

00:01:02.640 --> 00:01:05.210 
large medical centers involved in these
studies<00:01:03.080> probably<00:01:04.080> have<00:01:04.260> a<00:01:04.290> higher<00:01:04.619> mix<00:01:05.010> of

00:01:05.210 --> 00:01:05.220 
studies probably have a higher mix of

00:01:05.220 --> 00:01:07.760 
studies probably have a higher mix of
difficult<00:01:05.729> cases<00:01:06.090> as<00:01:06.840> smaller<00:01:07.380> clinics

00:01:07.760 --> 00:01:07.770 
difficult cases as smaller clinics

00:01:07.770 --> 00:01:10.280 
difficult cases as smaller clinics
referred<00:01:08.369> tougher<00:01:08.970> cases<00:01:09.240> to<00:01:09.659> these<00:01:09.840> larger

00:01:10.280 --> 00:01:10.290 
referred tougher cases to these larger

00:01:10.290 --> 00:01:13.280 
referred tougher cases to these larger
centers<00:01:11.570> occasionally<00:01:12.570> a<00:01:12.600> report<00:01:13.110> will

00:01:13.280 --> 00:01:13.290 
centers occasionally a report will

00:01:13.290 --> 00:01:15.170 
centers occasionally a report will
mention<00:01:13.680> the<00:01:13.830> occurrence<00:01:14.280> of<00:01:14.490> a<00:01:14.640> retinal<00:01:15.030> vein

00:01:15.170 --> 00:01:15.180 
mention the occurrence of a retinal vein

00:01:15.180 --> 00:01:17.240 
mention the occurrence of a retinal vein
occlusion<00:01:15.240> in<00:01:15.960> the<00:01:16.170> fellow<00:01:16.409> I<00:01:16.530> occurring

00:01:17.240 --> 00:01:17.250 
occlusion in the fellow I occurring

00:01:17.250 --> 00:01:19.999 
occlusion in the fellow I occurring
during<00:01:17.490> this<00:01:17.850> study<00:01:18.500> reports<00:01:19.500> like<00:01:19.740> these

00:01:19.999 --> 00:01:20.009 
during this study reports like these

00:01:20.009 --> 00:01:22.100 
during this study reports like these
confirm<00:01:20.580> that<00:01:20.850> this<00:01:21.030> type<00:01:21.299> of<00:01:21.330> trouble<00:01:21.960> in

00:01:22.100 --> 00:01:22.110 
confirm that this type of trouble in

00:01:22.110 --> 00:01:25.310 
confirm that this type of trouble in
both<00:01:22.439> eyes<00:01:22.740> does<00:01:23.220> occur<00:01:23.610> but<00:01:24.570> because<00:01:24.930> of<00:01:24.960> the

00:01:25.310 --> 00:01:25.320 
both eyes does occur but because of the

00:01:25.320 --> 00:01:27.590 
both eyes does occur but because of the
small<00:01:25.590> number<00:01:26.100> of<00:01:26.130> retinal<00:01:26.759> vein<00:01:26.939> occlusions

00:01:27.590 --> 00:01:27.600 
small number of retinal vein occlusions

00:01:27.600 --> 00:01:29.710 
small number of retinal vein occlusions
occurring<00:01:28.170> during<00:01:28.320> the<00:01:28.530> follow-up<00:01:28.950> period

00:01:29.710 --> 00:01:29.720 
occurring during the follow-up period

00:01:29.720 --> 00:01:31.969 
occurring during the follow-up period
estimating<00:01:30.720> the<00:01:30.930> likelihood<00:01:31.650> of<00:01:31.680> developing

00:01:31.969 --> 00:01:31.979 
estimating the likelihood of developing

00:01:31.979 --> 00:01:34.580 
estimating the likelihood of developing
a<00:01:32.549> retinal<00:01:33.030> vein<00:01:33.329> occlusion<00:01:33.390> in<00:01:34.170> the<00:01:34.350> fellow

00:01:34.580 --> 00:01:34.590 
a retinal vein occlusion in the fellow

00:01:34.590 --> 00:01:37.130 
a retinal vein occlusion in the fellow
eye<00:01:34.710> with<00:01:35.460> some<00:01:35.700> level<00:01:35.939> of<00:01:36.180> confidence<00:01:36.810> is

00:01:37.130 --> 00:01:37.140 
eye with some level of confidence is

00:01:37.140 --> 00:01:40.249 
eye with some level of confidence is
difficult<00:01:37.860> at<00:01:38.040> least<00:01:38.909> two<00:01:39.240> larger<00:01:39.840> studies

00:01:40.249 --> 00:01:40.259 
difficult at least two larger studies

00:01:40.259 --> 00:01:41.770 
difficult at least two larger studies
have<00:01:40.470> attempted<00:01:40.770> to<00:01:41.009> quantify<00:01:41.700> this

00:01:41.770 --> 00:01:41.780 
have attempted to quantify this

00:01:41.780 --> 00:01:46.370 
have attempted to quantify this
likelihood<00:01:43.070> in<00:01:44.149> 1994<00:01:45.149> dr.<00:01:45.630> hey<00:01:45.810> ray<00:01:46.049> and

00:01:46.370 --> 00:01:46.380 
likelihood in 1994 dr. hey ray and

00:01:46.380 --> 00:01:48.590 
likelihood in 1994 dr. hey ray and
fellow<00:01:46.649> researchers<00:01:47.460> reported<00:01:48.060> on<00:01:48.210> a<00:01:48.240> large

00:01:48.590 --> 00:01:48.600 
fellow researchers reported on a large

00:01:48.600 --> 00:01:50.960 
fellow researchers reported on a large
consecutive<00:01:49.470> series<00:01:49.950> of<00:01:50.189> patients<00:01:50.759> with

00:01:50.960 --> 00:01:50.970 
consecutive series of patients with

00:01:50.970 --> 00:01:53.389 
consecutive series of patients with
various<00:01:51.390> types<00:01:51.810> of<00:01:52.079> retinal<00:01:52.500> vein<00:01:52.680> occlusions

00:01:53.389 --> 00:01:53.399 
various types of retinal vein occlusions

00:01:53.399 --> 00:01:56.060 
various types of retinal vein occlusions
who<00:01:53.970> were<00:01:54.090> seen<00:01:54.420> at<00:01:54.600> the<00:01:54.750> University<00:01:55.439> of<00:01:55.470> Iowa

00:01:56.060 --> 00:01:56.070 
who were seen at the University of Iowa

00:01:56.070 --> 00:01:59.330 
who were seen at the University of Iowa
more<00:01:57.000> than<00:01:57.210> 1,100<00:01:58.049> patients<00:01:58.619> with<00:01:58.860> all<00:01:59.070> types

00:01:59.330 --> 00:01:59.340 
more than 1,100 patients with all types

00:01:59.340 --> 00:02:01.550 
more than 1,100 patients with all types
of<00:01:59.610> retinal<00:02:00.060> vein<00:02:00.210> occlusions<00:02:00.869> were<00:02:01.170> entered

00:02:01.550 --> 00:02:01.560 
of retinal vein occlusions were entered

00:02:01.560 --> 00:02:04.580 
of retinal vein occlusions were entered
into<00:02:01.740> this<00:02:02.070> study<00:02:02.509> including<00:02:03.509> Central<00:02:04.079> hema

00:02:04.580 --> 00:02:04.590 
into this study including Central hema

00:02:04.590 --> 00:02:06.499 
into this study including Central hema
central<00:02:05.100> and<00:02:05.310> branch<00:02:05.820> retinal<00:02:06.119> vein

00:02:06.499 --> 00:02:06.509 
central and branch retinal vein

00:02:06.509 --> 00:02:09.229 
central and branch retinal vein
occlusions<00:02:07.229> a<00:02:07.469> little<00:02:08.250> more<00:02:08.459> than<00:02:08.700> half<00:02:09.030> of

00:02:09.229 --> 00:02:09.239 
occlusions a little more than half of

00:02:09.239 --> 00:02:11.210 
occlusions a little more than half of
the<00:02:09.390> study<00:02:09.690> participants<00:02:09.959> were<00:02:10.770> central

00:02:11.210 --> 00:02:11.220 
the study participants were central

00:02:11.220 --> 00:02:13.340 
the study participants were central
retinal<00:02:11.580> vein<00:02:11.610> occlusion<00:02:11.989> patients

00:02:13.340 --> 00:02:13.350 
retinal vein occlusion patients

00:02:13.350 --> 00:02:15.320 
retinal vein occlusion patients
and<00:02:13.440> the<00:02:13.800> median<00:02:14.190> time<00:02:14.400> that<00:02:14.670> these<00:02:14.850> patients

00:02:15.320 --> 00:02:15.330 
and the median time that these patients

00:02:15.330 --> 00:02:17.150 
and the median time that these patients
were<00:02:15.450> involved<00:02:15.930> in<00:02:16.050> this<00:02:16.200> study<00:02:16.470> was<00:02:16.860> more

00:02:17.150 --> 00:02:17.160 
were involved in this study was more

00:02:17.160 --> 00:02:20.420 
were involved in this study was more
than<00:02:17.340> two<00:02:17.610> years<00:02:18.200> the<00:02:19.200> study<00:02:19.530> investigators

00:02:20.420 --> 00:02:20.430 
than two years the study investigators

00:02:20.430 --> 00:02:23.180 
than two years the study investigators
determined<00:02:21.150> that<00:02:21.270> if<00:02:21.510> an<00:02:21.750> individual<00:02:22.530> had<00:02:22.860> any

00:02:23.180 --> 00:02:23.190 
determined that if an individual had any

00:02:23.190 --> 00:02:25.940 
determined that if an individual had any
type<00:02:23.550> of<00:02:23.580> retinal<00:02:24.270> vein<00:02:24.450> occlusion<00:02:24.510> in<00:02:25.320> one

00:02:25.940 --> 00:02:25.950 
type of retinal vein occlusion in one

00:02:25.950 --> 00:02:28.280 
type of retinal vein occlusion in one
eye<00:02:25.980> the<00:02:26.880> estimated<00:02:27.540> chance<00:02:27.840> of<00:02:28.110> developing

00:02:28.280 --> 00:02:28.290 
eye the estimated chance of developing

00:02:28.290 --> 00:02:31.130 
eye the estimated chance of developing
any<00:02:29.040> type<00:02:29.490> of<00:02:29.520> retinal<00:02:30.090> vein<00:02:30.270> occlusion<00:02:30.330> in

00:02:31.130 --> 00:02:31.140 
any type of retinal vein occlusion in

00:02:31.140 --> 00:02:33.860 
any type of retinal vein occlusion in
the<00:02:31.290> fellow<00:02:31.560> I<00:02:31.680> was<00:02:32.640> a<00:02:32.670> little<00:02:33.090> under<00:02:33.570> eight

00:02:33.860 --> 00:02:33.870 
the fellow I was a little under eight

00:02:33.870 --> 00:02:36.200 
the fellow I was a little under eight
percent<00:02:34.470> at<00:02:34.710> two<00:02:35.040> years<00:02:35.340> from<00:02:35.670> the<00:02:35.850> date<00:02:36.060> of

00:02:36.200 --> 00:02:36.210 
percent at two years from the date of

00:02:36.210 --> 00:02:38.900 
percent at two years from the date of
the<00:02:36.510> original<00:02:36.770> occlusion<00:02:37.770> the<00:02:38.670> rate<00:02:38.880> of

00:02:38.900 --> 00:02:38.910 
the original occlusion the rate of

00:02:38.910 --> 00:02:41.150 
the original occlusion the rate of
occurrence<00:02:39.360> of<00:02:39.810> subsequent<00:02:40.290> retinal<00:02:41.010> vein

00:02:41.150 --> 00:02:41.160 
occurrence of subsequent retinal vein

00:02:41.160 --> 00:02:43.730 
occurrence of subsequent retinal vein
occlusions<00:02:41.820> in<00:02:42.030> the<00:02:42.120> fellow<00:02:42.360> eye<00:02:42.750> appeared<00:02:43.650> to

00:02:43.730 --> 00:02:43.740 
occlusions in the fellow eye appeared to

00:02:43.740 --> 00:02:45.770 
occlusions in the fellow eye appeared to
be<00:02:43.800> greatest<00:02:44.430> in<00:02:44.640> the<00:02:44.760> first<00:02:45.030> six<00:02:45.330> months

00:02:45.770 --> 00:02:45.780 
be greatest in the first six months

00:02:45.780 --> 00:02:48.770 
be greatest in the first six months
after<00:02:45.960> the<00:02:46.410> original<00:02:46.680> occlusion<00:02:47.640> after<00:02:48.570> that

00:02:48.770 --> 00:02:48.780 
after the original occlusion after that

00:02:48.780 --> 00:02:50.870 
after the original occlusion after that
time<00:02:49.050> point<00:02:49.410> the<00:02:49.830> rate<00:02:50.010> of<00:02:50.040> occurrence<00:02:50.460> was

00:02:50.870 --> 00:02:50.880 
time point the rate of occurrence was

00:02:50.880 --> 00:02:53.270 
time point the rate of occurrence was
reduced<00:02:51.420> but<00:02:51.960> continued<00:02:52.560> at<00:02:52.710> a<00:02:52.740> steady<00:02:53.130> rate

00:02:53.270 --> 00:02:53.280 
reduced but continued at a steady rate

00:02:53.280 --> 00:02:56.360 
reduced but continued at a steady rate
for<00:02:53.820> several<00:02:54.210> more<00:02:54.390> years<00:02:54.500> afterward<00:02:55.500> this

00:02:56.360 --> 00:02:56.370 
for several more years afterward this

00:02:56.370 --> 00:02:58.730 
for several more years afterward this
team<00:02:56.640> also<00:02:56.910> presented<00:02:57.630> information<00:02:57.990> on<00:02:58.530> the

00:02:58.730 --> 00:02:58.740 
team also presented information on the

00:02:58.740 --> 00:03:01.220 
team also presented information on the
estimated<00:02:59.220> likelihood<00:03:00.060> of<00:03:00.270> developing<00:03:00.540> the

00:03:01.220 --> 00:03:01.230 
estimated likelihood of developing the

00:03:01.230 --> 00:03:03.590 
estimated likelihood of developing the
exact<00:03:01.710> same<00:03:02.190> type<00:03:02.610> of<00:03:02.880> retinal<00:03:03.450> vein

00:03:03.590 --> 00:03:03.600 
exact same type of retinal vein

00:03:03.600 --> 00:03:07.130 
exact same type of retinal vein
occlusion<00:03:03.660> in<00:03:04.380> the<00:03:04.680> fellow<00:03:04.920> eye<00:03:05.570> for<00:03:06.570> example

00:03:07.130 --> 00:03:07.140 
occlusion in the fellow eye for example

00:03:07.140 --> 00:03:09.290 
occlusion in the fellow eye for example
if<00:03:07.590> nonischemic<00:03:08.220> central<00:03:08.940> retinal<00:03:09.270> vein

00:03:09.290 --> 00:03:09.300 
if nonischemic central retinal vein

00:03:09.300 --> 00:03:11.420 
if nonischemic central retinal vein
occlusion<00:03:09.480> was<00:03:10.200> present<00:03:10.650> in<00:03:10.770> the<00:03:11.010> study<00:03:11.310> I

00:03:11.420 --> 00:03:11.430 
occlusion was present in the study I

00:03:11.430 --> 00:03:13.520 
occlusion was present in the study I
there<00:03:12.240> was<00:03:12.360> about<00:03:12.600> a<00:03:12.660> six<00:03:13.050> and<00:03:13.230> a<00:03:13.350> half<00:03:13.380> percent

00:03:13.520 --> 00:03:13.530 
there was about a six and a half percent

00:03:13.530 --> 00:03:16.520 
there was about a six and a half percent
chance<00:03:14.280> of<00:03:14.610> developing<00:03:14.820> the<00:03:15.480> exact<00:03:15.900> same<00:03:16.200> type

00:03:16.520 --> 00:03:16.530 
chance of developing the exact same type

00:03:16.530 --> 00:03:19.730 
chance of developing the exact same type
of<00:03:16.560> occlusion<00:03:17.570> nonischemic<00:03:18.570> central<00:03:19.380> retinal

00:03:19.730 --> 00:03:19.740 
of occlusion nonischemic central retinal

00:03:19.740 --> 00:03:22.400 
of occlusion nonischemic central retinal
vein<00:03:19.770> occlusion<00:03:19.920> in<00:03:20.670> the<00:03:21.240> fellow<00:03:21.540> eye<00:03:21.660> during

00:03:22.400 --> 00:03:22.410 
vein occlusion in the fellow eye during

00:03:22.410 --> 00:03:24.340 
vein occlusion in the fellow eye during
the<00:03:22.530> first<00:03:22.740> two<00:03:23.040> years<00:03:23.070> after<00:03:23.730> the<00:03:24.150> initial

00:03:24.340 --> 00:03:24.350 
the first two years after the initial

00:03:24.350 --> 00:03:27.770 
the first two years after the initial
occlusion<00:03:25.760> but<00:03:26.760> information<00:03:27.420> on<00:03:27.630> the

00:03:27.770 --> 00:03:27.780 
occlusion but information on the

00:03:27.780 --> 00:03:29.750 
occlusion but information on the
likelihood<00:03:28.440> that<00:03:28.470> the<00:03:28.800> same<00:03:29.130> nonischemic

00:03:29.750 --> 00:03:29.760 
likelihood that the same nonischemic

00:03:29.760 --> 00:03:32.660 
likelihood that the same nonischemic
central<00:03:30.630> retinal<00:03:30.960> vein<00:03:30.990> occlusion<00:03:31.170> I<00:03:31.950> would

00:03:32.660 --> 00:03:32.670 
central retinal vein occlusion I would

00:03:32.670 --> 00:03:34.850 
central retinal vein occlusion I would
have<00:03:32.910> of<00:03:33.090> developing<00:03:33.750> any<00:03:34.050> other<00:03:34.380> type<00:03:34.830> of

00:03:34.850 --> 00:03:34.860 
have of developing any other type of

00:03:34.860 --> 00:03:37.570 
have of developing any other type of
retinal<00:03:35.490> vein<00:03:35.670> occlusion<00:03:35.730> was<00:03:36.570> not<00:03:36.840> presented

00:03:37.570 --> 00:03:37.580 
retinal vein occlusion was not presented

00:03:37.580 --> 00:03:40.190 
retinal vein occlusion was not presented
another<00:03:38.580> study<00:03:39.060> called<00:03:39.360> the<00:03:39.450> central<00:03:39.990> vein

00:03:40.190 --> 00:03:40.200 
another study called the central vein

00:03:40.200 --> 00:03:43.280 
another study called the central vein
occlusion<00:03:40.830> study<00:03:41.180> considered<00:03:42.180> only<00:03:42.390> central

00:03:43.280 --> 00:03:43.290 
occlusion study considered only central

00:03:43.290 --> 00:03:46.040 
occlusion study considered only central
retinal<00:03:43.710> vein<00:03:43.740> occlusion<00:03:44.210> patients<00:03:45.210> this

00:03:46.040 --> 00:03:46.050 
retinal vein occlusion patients this

00:03:46.050 --> 00:03:49.070 
retinal vein occlusion patients this
study<00:03:46.350> was<00:03:46.470> concluded<00:03:47.340> in<00:03:47.520> the<00:03:47.730> early<00:03:48.120> 1990s

00:03:49.070 --> 00:03:49.080 
study was concluded in the early 1990s

00:03:49.080 --> 00:03:52.310 
study was concluded in the early 1990s
and<00:03:49.320> involved<00:03:50.100> more<00:03:50.310> than<00:03:50.550> 700<00:03:51.360> patients<00:03:51.630> the

00:03:52.310 --> 00:03:52.320 
and involved more than 700 patients the

00:03:52.320 --> 00:03:54.230 
and involved more than 700 patients the
majority<00:03:52.710> of<00:03:52.920> whom<00:03:53.190> were<00:03:53.400> followed<00:03:53.820> for<00:03:54.030> more

00:03:54.230 --> 00:03:54.240 
majority of whom were followed for more

00:03:54.240 --> 00:03:57.080 
majority of whom were followed for more
than<00:03:54.420> two<00:03:54.660> years<00:03:55.140> the<00:03:55.860> study<00:03:56.220> investigators

00:03:57.080 --> 00:03:57.090 
than two years the study investigators

00:03:57.090 --> 00:03:58.970 
than two years the study investigators
estimated<00:03:57.330> that<00:03:58.020> the<00:03:58.230> chance<00:03:58.530> of<00:03:58.770> developing

00:03:58.970 --> 00:03:58.980 
estimated that the chance of developing

00:03:58.980 --> 00:04:01.580 
estimated that the chance of developing
any<00:03:59.700> type<00:04:00.120> of<00:04:00.150> retinal<00:04:00.810> vascular<00:04:01.470> occlusion

00:04:01.580 --> 00:04:01.590 
any type of retinal vascular occlusion

00:04:01.590 --> 00:04:04.910 
any type of retinal vascular occlusion
in<00:04:02.220> the<00:04:02.730> fellow<00:04:02.970> I<00:04:03.210> was<00:04:03.630> about<00:04:03.930> one<00:04:04.260> percent

00:04:04.910 --> 00:04:04.920 
in the fellow I was about one percent

00:04:04.920 --> 00:04:08.210 
in the fellow I was about one percent
per<00:04:05.250> year<00:04:05.820> in<00:04:06.690> other<00:04:06.900> words<00:04:07.230> the<00:04:07.590> chance<00:04:07.920> of

00:04:08.210 --> 00:04:08.220 
per year in other words the chance of

00:04:08.220 --> 00:04:11.150 
per year in other words the chance of
developing<00:04:08.370> a<00:04:09.060> central<00:04:09.600> or<00:04:09.780> branch<00:04:10.320> or<00:04:10.740> hema

00:04:11.150 --> 00:04:11.160 
developing a central or branch or hema

00:04:11.160 --> 00:04:13.730 
developing a central or branch or hema
central<00:04:11.700> retinal<00:04:12.120> vein<00:04:12.150> occlusion<00:04:12.330> or<00:04:13.080> any

00:04:13.730 --> 00:04:13.740 
central retinal vein occlusion or any

00:04:13.740 --> 00:04:15.520 
central retinal vein occlusion or any
other<00:04:14.040> type<00:04:14.340> of<00:04:14.400> vascular<00:04:15.240> occlusion

00:04:15.520 --> 00:04:15.530 
other type of vascular occlusion

00:04:15.530 --> 00:04:18.229 
other type of vascular occlusion
including<00:04:16.530> arterial<00:04:17.220> occlusion<00:04:17.760> zin<00:04:18.150> the

00:04:18.229 --> 00:04:18.239 
including arterial occlusion zin the

00:04:18.239 --> 00:04:21.890 
including arterial occlusion zin the
fellow<00:04:18.480> I<00:04:18.600> would<00:04:19.530> be<00:04:19.739> about<00:04:19.980> 1%<00:04:20.780> during<00:04:21.780> the

00:04:21.890 --> 00:04:21.900 
fellow I would be about 1% during the

00:04:21.900 --> 00:04:24.469 
fellow I would be about 1% during the
first<00:04:22.200> year<00:04:22.530> or<00:04:23.130> two<00:04:23.190> percent<00:04:24.060> during<00:04:24.270> the

00:04:24.469 --> 00:04:24.479 
first year or two percent during the

00:04:24.479 --> 00:04:27.270 
first year or two percent during the
first<00:04:24.750> two<00:04:25.080> years<00:04:25.110> or<00:04:25.740> three<00:04:26.030> percent

00:04:27.270 --> 00:04:27.280 
first two years or three percent

00:04:27.280 --> 00:04:30.330 
first two years or three percent
in<00:04:27.340> the<00:04:27.430> first<00:04:27.700> three<00:04:28.090> years<00:04:28.120> and<00:04:28.780> so<00:04:29.080> on<00:04:29.340> the

00:04:30.330 --> 00:04:30.340 
in the first three years and so on the

00:04:30.340 --> 00:04:32.640 
in the first three years and so on the
vascular<00:04:30.940> occlusions<00:04:31.660> that<00:04:31.900> occurred<00:04:32.290> in<00:04:32.500> the

00:04:32.640 --> 00:04:32.650 
vascular occlusions that occurred in the

00:04:32.650 --> 00:04:34.710 
vascular occlusions that occurred in the
fellow<00:04:32.889> eye<00:04:33.010> during<00:04:33.430> the<00:04:33.700> study<00:04:33.880> follow-up<00:04:34.570> of

00:04:34.710 --> 00:04:34.720 
fellow eye during the study follow-up of

00:04:34.720 --> 00:04:36.960 
fellow eye during the study follow-up of
our<00:04:35.320> half<00:04:35.680> or<00:04:36.070> central<00:04:36.580> retinal<00:04:36.940> vein

00:04:36.960 --> 00:04:36.970 
our half or central retinal vein

00:04:36.970 --> 00:04:40.350 
our half or central retinal vein
occlusions<00:04:38.130> it's<00:04:39.130> entirely<00:04:39.639> possible<00:04:40.000> that

00:04:40.350 --> 00:04:40.360 
occlusions it's entirely possible that

00:04:40.360 --> 00:04:42.840 
occlusions it's entirely possible that
the<00:04:40.750> studies<00:04:41.139> discussed<00:04:41.650> in<00:04:41.830> this<00:04:41.980> video<00:04:42.220> may

00:04:42.840 --> 00:04:42.850 
the studies discussed in this video may

00:04:42.850 --> 00:04:44.850 
the studies discussed in this video may
overestimate<00:04:43.389> the<00:04:44.139> likelihood<00:04:44.740> of

00:04:44.850 --> 00:04:44.860 
overestimate the likelihood of

00:04:44.860 --> 00:04:46.980 
overestimate the likelihood of
developing<00:04:45.100> retinal<00:04:45.910> vein<00:04:46.060> occlusions<00:04:46.720> in

00:04:46.980 --> 00:04:46.990 
developing retinal vein occlusions in

00:04:46.990 --> 00:04:50.010 
developing retinal vein occlusions in
the<00:04:47.139> fellow<00:04:47.380> I<00:04:48.090> smaller<00:04:49.090> practices<00:04:49.419> in

00:04:50.010 --> 00:04:50.020 
the fellow I smaller practices in

00:04:50.020 --> 00:04:52.530 
the fellow I smaller practices in
clinics<00:04:50.500> often<00:04:51.040> refer<00:04:51.430> more<00:04:51.669> difficult<00:04:52.240> cases

00:04:52.530 --> 00:04:52.540 
clinics often refer more difficult cases

00:04:52.540 --> 00:04:55.650 
clinics often refer more difficult cases
to<00:04:52.990> larger<00:04:53.560> well-regarded<00:04:54.480> institutions<00:04:55.480> and

00:04:55.650 --> 00:04:55.660 
to larger well-regarded institutions and

00:04:55.660 --> 00:04:58.440 
to larger well-regarded institutions and
practices<00:04:55.980> where<00:04:56.980> these<00:04:57.190> types<00:04:57.550> of<00:04:57.700> I<00:04:57.910> studies

00:04:58.440 --> 00:04:58.450 
practices where these types of I studies

00:04:58.450 --> 00:05:00.990 
practices where these types of I studies
are<00:04:58.690> usually<00:04:59.169> carried<00:04:59.530> out<00:04:59.740> of<00:05:00.040> all<00:05:00.790> the

00:05:00.990 --> 00:05:01.000 
are usually carried out of all the

00:05:01.000 --> 00:05:03.060 
are usually carried out of all the
people<00:05:01.150> who<00:05:01.480> get<00:05:01.720> retinal<00:05:02.260> vein<00:05:02.410> occlusions

00:05:03.060 --> 00:05:03.070 
people who get retinal vein occlusions

00:05:03.070 --> 00:05:05.190 
people who get retinal vein occlusions
many<00:05:03.460> of<00:05:03.610> the<00:05:03.730> more<00:05:03.910> difficult<00:05:04.150> cases<00:05:04.840> are

00:05:05.190 --> 00:05:05.200 
many of the more difficult cases are

00:05:05.200 --> 00:05:07.409 
many of the more difficult cases are
referred<00:05:05.380> to<00:05:05.650> the<00:05:06.010> larger<00:05:06.430> institutions

00:05:07.409 --> 00:05:07.419 
referred to the larger institutions

00:05:07.419 --> 00:05:10.140 
referred to the larger institutions
leaving<00:05:08.380> these<00:05:08.560> larger<00:05:09.040> institutions<00:05:09.910> with

00:05:10.140 --> 00:05:10.150 
leaving these larger institutions with

00:05:10.150 --> 00:05:12.690 
leaving these larger institutions with
the<00:05:10.300> disproportionate<00:05:11.260> number<00:05:11.680> of<00:05:11.710> older<00:05:12.250> or

00:05:12.690 --> 00:05:12.700 
the disproportionate number of older or

00:05:12.700 --> 00:05:15.659 
the disproportionate number of older or
sicker<00:05:12.730> or<00:05:13.510> more<00:05:13.930> severe<00:05:14.470> cases<00:05:14.800> which

00:05:15.659 --> 00:05:15.669 
sicker or more severe cases which

00:05:15.669 --> 00:05:17.670 
sicker or more severe cases which
perhaps<00:05:15.910> leads<00:05:16.480> to<00:05:16.720> a<00:05:16.750> higher<00:05:17.050> rate<00:05:17.410> of

00:05:17.670 --> 00:05:17.680 
perhaps leads to a higher rate of

00:05:17.680 --> 00:05:20.340 
perhaps leads to a higher rate of
occlusion<00:05:18.370> in<00:05:18.580> the<00:05:18.790> fellow<00:05:19.060> eye<00:05:19.270> in<00:05:19.690> studies

00:05:20.340 --> 00:05:20.350 
occlusion in the fellow eye in studies

00:05:20.350 --> 00:05:23.730 
occlusion in the fellow eye in studies
like<00:05:20.590> these<00:05:21.810> population-based<00:05:22.810> studies<00:05:23.500> like

00:05:23.730 --> 00:05:23.740 
like these population-based studies like

00:05:23.740 --> 00:05:26.340 
like these population-based studies like
the<00:05:23.890> Beaver<00:05:24.250> Dam<00:05:24.280> I<00:05:24.760> study<00:05:25.240> and<00:05:25.510> the<00:05:26.110> Blue

00:05:26.340 --> 00:05:26.350 
the Beaver Dam I study and the Blue

00:05:26.350 --> 00:05:28.980 
the Beaver Dam I study and the Blue
Mountains<00:05:26.830> I<00:05:27.040> study<00:05:27.460> were<00:05:27.850> large<00:05:28.270> segments<00:05:28.930> of

00:05:28.980 --> 00:05:28.990 
Mountains I study were large segments of

00:05:28.990 --> 00:05:31.110 
Mountains I study were large segments of
a<00:05:29.229> general<00:05:29.590> population<00:05:30.430> or<00:05:30.550> followed<00:05:30.970> over

00:05:31.110 --> 00:05:31.120 
a general population or followed over

00:05:31.120 --> 00:05:33.870 
a general population or followed over
long<00:05:31.479> period<00:05:31.990> of<00:05:32.020> time<00:05:32.280> appear<00:05:33.280> to<00:05:33.400> show<00:05:33.610> lower

00:05:33.870 --> 00:05:33.880 
long period of time appear to show lower

00:05:33.880 --> 00:05:36.030 
long period of time appear to show lower
rates<00:05:34.240> of<00:05:34.510> retinal<00:05:34.870> vein<00:05:35.020> occlusions<00:05:35.650> in<00:05:35.919> the

00:05:36.030 --> 00:05:36.040 
rates of retinal vein occlusions in the

00:05:36.040 --> 00:05:38.250 
rates of retinal vein occlusions in the
fellow<00:05:36.280> eye<00:05:36.690> but<00:05:37.690> the<00:05:37.840> number<00:05:38.140> of

00:05:38.250 --> 00:05:38.260 
fellow eye but the number of

00:05:38.260 --> 00:05:40.170 
fellow eye but the number of
participants<00:05:38.919> developing<00:05:39.669> retinal<00:05:40.030> vein

00:05:40.170 --> 00:05:40.180 
participants developing retinal vein

00:05:40.180 --> 00:05:42.330 
participants developing retinal vein
occlusions<00:05:40.810> during<00:05:41.200> these<00:05:41.350> studies<00:05:41.800> is<00:05:42.010> small

00:05:42.330 --> 00:05:42.340 
occlusions during these studies is small

00:05:42.340 --> 00:05:44.520 
occlusions during these studies is small
and<00:05:42.640> the<00:05:42.870> participants<00:05:43.870> developing<00:05:44.440> a

00:05:44.520 --> 00:05:44.530 
and the participants developing a

00:05:44.530 --> 00:05:46.350 
and the participants developing a
retinal<00:05:44.890> vein<00:05:45.010> occlusion<00:05:45.070> in<00:05:45.789> the<00:05:45.940> fellow<00:05:46.210> eye

00:05:46.350 --> 00:05:46.360 
retinal vein occlusion in the fellow eye

00:05:46.360 --> 00:05:49.440 
retinal vein occlusion in the fellow eye
is<00:05:46.780> even<00:05:47.200> smaller<00:05:47.550> making<00:05:48.550> these<00:05:48.700> rates<00:05:49.090> more

00:05:49.440 --> 00:05:49.450 
is even smaller making these rates more

00:05:49.450 --> 00:05:52.980 
is even smaller making these rates more
prone<00:05:49.810> to<00:05:49.860> anomalies<00:05:50.860> of<00:05:51.070> chance<00:05:51.990> nonetheless

00:05:52.980 --> 00:05:52.990 
prone to anomalies of chance nonetheless

00:05:52.990 --> 00:05:55.529 
prone to anomalies of chance nonetheless
these<00:05:53.560> population-based<00:05:54.430> studies<00:05:55.090> hold<00:05:55.360> out

00:05:55.529 --> 00:05:55.539 
these population-based studies hold out

00:05:55.539 --> 00:05:57.810 
these population-based studies hold out
at<00:05:55.840> least<00:05:56.020> the<00:05:56.260> possibility<00:05:56.440> that<00:05:57.010> rates<00:05:57.580> of

00:05:57.810 --> 00:05:57.820 
at least the possibility that rates of

00:05:57.820 --> 00:05:59.719 
at least the possibility that rates of
retinal<00:05:58.240> vein<00:05:58.419> occlusion<00:05:58.479> in<00:05:59.229> the<00:05:59.350> fellow<00:05:59.620> I

00:05:59.719 --> 00:05:59.729 
retinal vein occlusion in the fellow I

00:05:59.729 --> 00:06:02.190 
retinal vein occlusion in the fellow I
might<00:06:00.729> be<00:06:00.910> a<00:06:00.940> good<00:06:01.180> bit<00:06:01.419> smaller<00:06:01.810> in<00:06:02.140> the

00:06:02.190 --> 00:06:02.200 
might be a good bit smaller in the

00:06:02.200 --> 00:06:04.800 
might be a good bit smaller in the
general<00:06:02.860> population<00:06:03.419> then<00:06:04.419> the<00:06:04.600> rates

00:06:04.800 --> 00:06:04.810 
general population then the rates

00:06:04.810 --> 00:06:06.920 
general population then the rates
discussed<00:06:05.350> earlier<00:06:05.800> derived<00:06:06.310> from<00:06:06.580> large

00:06:06.920 --> 00:06:06.930 
discussed earlier derived from large

00:06:06.930 --> 00:06:10.440 
discussed earlier derived from large
institutions<00:06:07.930> and<00:06:08.200> medical<00:06:08.680> practices<00:06:09.450> to

00:06:10.440 --> 00:06:10.450 
institutions and medical practices to

00:06:10.450 --> 00:06:12.180 
institutions and medical practices to
sum<00:06:10.660> up<00:06:10.690> and<00:06:11.140> although<00:06:11.650> retinal<00:06:12.039> vein

00:06:12.180 --> 00:06:12.190 
sum up and although retinal vein

00:06:12.190 --> 00:06:15.330 
sum up and although retinal vein
occlusion<00:06:12.390> sometimes<00:06:13.390> affect<00:06:13.900> both<00:06:14.229> eyes<00:06:14.530> the

00:06:15.330 --> 00:06:15.340 
occlusion sometimes affect both eyes the

00:06:15.340 --> 00:06:17.460 
occlusion sometimes affect both eyes the
large<00:06:15.580> majority<00:06:16.090> of<00:06:16.330> patients<00:06:16.690> will<00:06:17.110> not<00:06:17.289> have

00:06:17.460 --> 00:06:17.470 
large majority of patients will not have

00:06:17.470 --> 00:06:19.310 
large majority of patients will not have
to<00:06:17.620> deal<00:06:17.860> with<00:06:18.070> this<00:06:18.280> type<00:06:18.520> of<00:06:18.580> problem

00:06:19.310 --> 00:06:19.320 
to deal with this type of problem

00:06:19.320 --> 00:06:21.240 
to deal with this type of problem
knowing<00:06:20.320> that<00:06:20.350> this<00:06:20.650> kind<00:06:20.919> of<00:06:20.979> problem

00:06:21.240 --> 00:06:21.250 
knowing that this kind of problem

00:06:21.250 --> 00:06:23.790 
knowing that this kind of problem
occasionally<00:06:21.910> happens<00:06:22.539> gives<00:06:23.289> us<00:06:23.530> as

00:06:23.790 --> 00:06:23.800 
occasionally happens gives us as

00:06:23.800 --> 00:06:25.710 
occasionally happens gives us as
patients<00:06:24.010> the<00:06:24.490> opportunity<00:06:25.300> to<00:06:25.510> work<00:06:25.690> with

00:06:25.710 --> 00:06:25.720 
patients the opportunity to work with

00:06:25.720 --> 00:06:28.080 
patients the opportunity to work with
our<00:06:26.110> doctors<00:06:26.560> to<00:06:27.250> take<00:06:27.460> steps<00:06:27.760> to<00:06:28.000> eliminate

00:06:28.080 --> 00:06:28.090 
our doctors to take steps to eliminate

00:06:28.090 --> 00:06:30.990 
our doctors to take steps to eliminate
any<00:06:28.750> risk<00:06:29.229> factors<00:06:29.740> we<00:06:29.919> may<00:06:30.130> have<00:06:30.370> for<00:06:30.640> retinal

00:06:30.990 --> 00:06:31.000 
any risk factors we may have for retinal

00:06:31.000 --> 00:06:33.360 
any risk factors we may have for retinal
vein<00:06:31.150> occlusion<00:06:31.210> and<00:06:32.020> to<00:06:32.620> start<00:06:32.890> doing<00:06:33.039> more

00:06:33.360 --> 00:06:33.370 
vein occlusion and to start doing more

00:06:33.370 --> 00:06:35.130 
vein occlusion and to start doing more
of<00:06:33.430> the<00:06:33.520> common<00:06:33.970> sense<00:06:34.270> things<00:06:34.660> to<00:06:34.960> take

00:06:35.130 --> 00:06:35.140 
of the common sense things to take

00:06:35.140 --> 00:06:37.979 
of the common sense things to take
better<00:06:35.349> care<00:06:35.470> of<00:06:35.740> ourselves

